$0.20
+0.01 (+4.13%)
Open$0.20
Previous Close$0.19
Day High$0.20
Day Low$0.18
52W High$0.45
52W Low$0.08
Volume—
Avg Volume507.4K
Market Cap21.14M
P/E Ratio—
EPS$-0.08
SectorPharmaceuticals
Analyst Ratings
Strong Buy
5 analysts
Price Target
+7,847.2% upside
Current
$0.20
$0.20
Target
$15.64
$15.64
$13.90
$15.64 avg
$22.29
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.12M | 1.14M | 13.95M |
| Net Income | -5,335,891 | -4,876,423 | 2.16M |
| Profit Margin | -477.1% | -453.3% | 15.5% |
| EBITDA | -9,540,620 | -9,203,481 | 3.52M |
| Free Cash Flow | — | — | 2.06M |
| Rev Growth | -1.5% | -1.5% | +17.1% |
| Debt/Equity | 0.02 | 0.02 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,368.84 | +0.30% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $274.87 | +0.94% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $147.01 | +0.05% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.30 | -1.94% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $62.89 | -0.38% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $79.81 | -2.80% | 12.3 | 32.24B |